Tenet Healthcare Corporation $THC Shares Acquired by B. Metzler seel. Sohn & Co. AG

Key Points

• B. Metzler seel. Sohn & Co. AG increased its holdings in Tenet Healthcare Corporation by 65.1%, owning 13,173 shares valued at $1.77 million after acquiring an additional 5,196 shares this quarter.
• Tenet Healthcare reported earnings per share of $4.02 for the quarter, exceeding analysts' expectations, and forecasted FY 2025 EPS guidance between 15.550-16.210.
• Several analysts have increased their target prices for Tenet Healthcare, with Morgan Stanley raising it to $210.00 and a consensus target price now at $192.69.

B. Metzler seel. Sohn & Co. AG lifted its position in Tenet Healthcare Corporation (NYSE:THC - Free Report) by 65.1% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,173 shares of the company's stock after acquiring an additional 5,196 shares during the quarter. B. Metzler seel. Sohn & Co. AG's holdings in Tenet Healthcare were worth $1,772,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new stake in shares of Tenet Healthcare in the 1st quarter worth approximately $26,000. Wayfinding Financial LLC purchased a new stake in shares of Tenet Healthcare in the 1st quarter worth approximately $28,000. SVB Wealth LLC purchased a new stake in shares of Tenet Healthcare in the 1st quarter worth approximately $30,000. N.E.W. Advisory Services LLC purchased a new stake in shares of Tenet Healthcare in the 1st quarter worth approximately $31,000. Finally, Brooklyn Investment Group lifted its position in shares of Tenet Healthcare by 908.7% in the 1st quarter. Brooklyn Investment Group now owns 232 shares of the company's stock worth $31,000 after purchasing an additional 209 shares during the period. Hedge funds and other institutional investors own 95.44% of the company's stock.

Insider Buying and Selling at Tenet Healthcare

In related news, EVP Paola M. Arbour sold 7,738 shares of the firm's stock in a transaction on Thursday, June 5th. The shares were sold at an average price of $173.00, for a total transaction of $1,338,674.00. Following the sale, the executive vice president owned 20,110 shares in the company, valued at approximately $3,479,030. This trade represents a 27.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Lisa Y. Foo sold 8,000 shares of the firm's stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $179.53, for a total transaction of $1,436,240.00. Following the sale, the executive vice president owned 20,878 shares in the company, valued at approximately $3,748,227.34. This represents a 27.70% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 20,534 shares of company stock worth $3,618,237 over the last ninety days. 0.81% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the stock. Robert W. Baird lowered their price target on shares of Tenet Healthcare from $195.00 to $167.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Truist Financial increased their target price on shares of Tenet Healthcare from $190.00 to $205.00 and gave the company a "buy" rating in a research report on Wednesday, July 16th. Barclays decreased their target price on shares of Tenet Healthcare from $215.00 to $208.00 and set an "overweight" rating for the company in a research report on Thursday, July 24th. UBS Group increased their target price on shares of Tenet Healthcare from $230.00 to $238.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. Finally, Guggenheim increased their target price on shares of Tenet Healthcare from $180.00 to $188.00 and gave the company a "buy" rating in a research report on Wednesday, July 23rd. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Tenet Healthcare has a consensus rating of "Moderate Buy" and an average price target of $192.69.

Tenet Healthcare Stock Performance

Tenet Healthcare stock traded up $0.54 during mid-day trading on Wednesday, reaching $185.89. 309,035 shares of the company traded hands, compared to its average volume of 1,511,828. The company has a debt-to-equity ratio of 2.39, a current ratio of 1.71 and a quick ratio of 1.63. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $186.80. The company has a market capitalization of $16.42 billion, a price-to-earnings ratio of 11.90, a price-to-earnings-growth ratio of 0.79 and a beta of 1.55. The firm's fifty day moving average is $170.76 and its two-hundred day moving average is $151.92.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The company reported $4.02 earnings per share for the quarter, topping analysts' consensus estimates of $2.84 by $1.18. The firm had revenue of $5.27 billion for the quarter, compared to analyst estimates of $5.16 billion. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. The business's quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.31 earnings per share. Tenet Healthcare has set its FY 2025 guidance at 15.550-16.210 EPS. On average, equities research analysts expect that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.